Item Type | Name |
Academic Article
|
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
|
Academic Article
|
ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer.
|
Academic Article
|
Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.
|
Academic Article
|
The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck.
|
Academic Article
|
A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase.
|
Academic Article
|
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3.
|
Academic Article
|
Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.
|
Academic Article
|
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.
|
Academic Article
|
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
|
Academic Article
|
Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium.
|
Academic Article
|
Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy.
|
Academic Article
|
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability.
|
Academic Article
|
Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.
|
Concept
|
Cell Line, Tumor
|
Academic Article
|
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.
|
Academic Article
|
PTK6 regulates IGF-1-induced anchorage-independent survival.
|
Academic Article
|
A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.
|
Academic Article
|
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
|
Academic Article
|
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
|
Academic Article
|
Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling.
|
Academic Article
|
Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
|
Academic Article
|
Genome-wide transcriptome profiling of homologous recombination DNA repair.
|
Academic Article
|
Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules.
|
Academic Article
|
Unraveling the regulatory connections between two controllers of breast cancer cell fate.
|
Academic Article
|
Definition of PKC-a, CDK6, and MET as therapeutic targets in triple-negative breast cancer.
|
Academic Article
|
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks.
|
Academic Article
|
A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.
|
Academic Article
|
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.
|
Academic Article
|
Functional consequence of the MET-T1010I polymorphism in breast cancer.
|
Academic Article
|
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells.
|
Academic Article
|
Determinants of rapamycin sensitivity in breast cancer cells.
|
Academic Article
|
Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.
|
Academic Article
|
An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
|
Academic Article
|
Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt.
|
Academic Article
|
Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments.
|
Academic Article
|
Pharmacodynamic markers of perifosine efficacy.
|
Academic Article
|
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
|
Academic Article
|
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
|
Academic Article
|
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.
|
Academic Article
|
Vimentin is a novel AKT1 target mediating motility and invasion.
|
Academic Article
|
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death.
|
Academic Article
|
ERa-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer.
|
Academic Article
|
Androgen regulation of 5a-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
|
Academic Article
|
Detection algorithm for the validation of human cell lines.
|
Academic Article
|
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition.
|
Academic Article
|
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.
|
Academic Article
|
Mechanistic basis for overcoming platinum resistance using copper chelating agents.
|
Academic Article
|
Systematic identification of combinatorial drivers and targets in cancer cell lines.
|
Academic Article
|
Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.
|
Academic Article
|
Modeling precision treatment of breast cancer.
|
Academic Article
|
Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations.
|
Academic Article
|
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
|
Academic Article
|
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias.
|
Academic Article
|
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.
|
Academic Article
|
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.
|
Academic Article
|
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma.
|
Academic Article
|
Autophosphorylation of Akt at threonine 72 and serine 246. A potential mechanism of regulation of Akt kinase activity.
|
Academic Article
|
Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
|
Academic Article
|
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.
|
Academic Article
|
The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.
|
Academic Article
|
Alkoxymethylenephosphonate analogues of (Lyso) phosphatidic acid stimulate signaling networks coupled to the LPA2 receptor.
|
Academic Article
|
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.
|
Academic Article
|
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer.
|
Academic Article
|
A sequence-based survey of the complex structural organization of tumor genomes.
|
Academic Article
|
Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha.
|
Academic Article
|
Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.
|
Academic Article
|
Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance.
|
Academic Article
|
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
|
Academic Article
|
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.
|
Academic Article
|
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
|
Academic Article
|
Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.
|
Academic Article
|
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.
|
Academic Article
|
Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells.
|
Academic Article
|
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.
|
Academic Article
|
Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.
|
Academic Article
|
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition.
|
Academic Article
|
MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells.
|
Academic Article
|
Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.
|
Academic Article
|
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
|
Academic Article
|
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.
|
Academic Article
|
Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.
|
Academic Article
|
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
|
Academic Article
|
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
|
Academic Article
|
EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol.
|
Academic Article
|
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.
|
Academic Article
|
Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520.
|
Academic Article
|
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer.
|
Academic Article
|
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation.
|
Academic Article
|
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.
|
Academic Article
|
Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.
|
Academic Article
|
A genetically defined model for human ovarian cancer.
|
Academic Article
|
Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
|
Academic Article
|
A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
|
Academic Article
|
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.
|
Academic Article
|
Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma.
|
Academic Article
|
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
|
Academic Article
|
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.
|
Academic Article
|
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
|
Academic Article
|
Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.
|
Academic Article
|
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.
|
Academic Article
|
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
|
Academic Article
|
A novel AKT3 mutation in melanoma tumours and cell lines.
|
Academic Article
|
A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.
|
Academic Article
|
Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
|
Academic Article
|
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
|
Academic Article
|
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1.
|
Academic Article
|
Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.
|
Academic Article
|
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.
|
Academic Article
|
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.
|
Academic Article
|
Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis.
|
Academic Article
|
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.
|
Academic Article
|
A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance.
|
Academic Article
|
Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis.
|
Academic Article
|
A time-series DDP for functional proteomics profiles.
|
Academic Article
|
Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR.
|
Academic Article
|
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.
|
Academic Article
|
Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2.
|
Academic Article
|
AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis.
|
Academic Article
|
Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells.
|
Academic Article
|
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.
|
Academic Article
|
EVI1 splice variants modulate functional responses in ovarian cancer cells.
|
Academic Article
|
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.
|
Academic Article
|
Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer.
|
Academic Article
|
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.
|
Academic Article
|
Perturbation biology: inferring signaling networks in cellular systems.
|
Academic Article
|
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer.
|
Academic Article
|
Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling.
|
Academic Article
|
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
|
Academic Article
|
Network topology determines dynamics of the mammalian MAPK1,2 signaling network: bifan motif regulation of C-Raf and B-Raf isoforms by FGFR and MC1R.
|
Academic Article
|
A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
|
Academic Article
|
Systematic analysis of genotype-specific drug responses in cancer.
|
Academic Article
|
Network inference using steady-state data and Goldbeter-Koshland kinetics. [corrected].
|
Academic Article
|
Bayesian inference of signaling network topology in a cancer cell line.
|
Academic Article
|
Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCa invasive signaling axis.
|
Academic Article
|
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.
|
Academic Article
|
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
|
Academic Article
|
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
|
Academic Article
|
Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity.
|
Academic Article
|
Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line.
|
Academic Article
|
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia.
|
Academic Article
|
Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.
|
Academic Article
|
Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
|
Academic Article
|
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.
|
Academic Article
|
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.
|
Academic Article
|
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
|
Academic Article
|
Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
|
Academic Article
|
Subtype and pathway specific responses to anticancer compounds in breast cancer.
|
Academic Article
|
Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.
|
Academic Article
|
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer.
|
Academic Article
|
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.
|
Academic Article
|
Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
|
Academic Article
|
YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.
|
Academic Article
|
Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein.
|
Academic Article
|
A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapy.
|
Academic Article
|
Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer.
|
Academic Article
|
Autophagy mediates HIF2a degradation and suppresses renal tumorigenesis.
|
Academic Article
|
Peroxiredoxin-1 protects estrogen receptor a from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.
|
Academic Article
|
The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF.
|
Academic Article
|
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.
|
Academic Article
|
Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D.
|
Academic Article
|
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.
|
Academic Article
|
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1a and oxidative phosphorylation in melanoma.
|
Academic Article
|
Spatial normalization of reverse phase protein array data.
|
Academic Article
|
a-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration.
|
Academic Article
|
Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
|
Academic Article
|
Characterization of the role Rab25 in energy metabolism and cancer using extracellular flux analysis and material balance.
|
Academic Article
|
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
|
Academic Article
|
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
|
Academic Article
|
Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
|
Academic Article
|
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.
|
Academic Article
|
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
|
Academic Article
|
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
|
Academic Article
|
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
|
Academic Article
|
A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.
|
Academic Article
|
Glucose starvation induces mutation and lineage-dependent adaptive responses in a large collection of cancer cell lines.
|
Academic Article
|
Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations.
|
Academic Article
|
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.
|
Academic Article
|
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.
|
Academic Article
|
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.
|
Academic Article
|
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer.
|
Academic Article
|
Functional annotation of rare gene aberration drivers of pancreatic cancer.
|
Academic Article
|
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.
|
Academic Article
|
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
|
Academic Article
|
Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.
|
Academic Article
|
Role of RPL39 in Metaplastic Breast Cancer.
|
Academic Article
|
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.
|
Academic Article
|
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.
|
Academic Article
|
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
|
Academic Article
|
A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.
|
Academic Article
|
Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.
|
Academic Article
|
PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
|
Academic Article
|
The ErbB2?Ex16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
|
Academic Article
|
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.
|
Academic Article
|
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
|
Academic Article
|
Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.
|
Academic Article
|
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer.
|
Academic Article
|
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
|
Academic Article
|
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
|
Academic Article
|
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype.
|
Academic Article
|
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance.
|
Academic Article
|
Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.
|
Academic Article
|
Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
|
Academic Article
|
Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p.
|
Academic Article
|
Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development.
|
Academic Article
|
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
|
Academic Article
|
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.
|
Academic Article
|
YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
|
Academic Article
|
ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAP.
|
Academic Article
|
Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer.
|
Academic Article
|
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
|
Academic Article
|
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-?B Pathway in Melanoma.
|
Academic Article
|
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer.
|
Academic Article
|
A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles.
|
Academic Article
|
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
|
Academic Article
|
ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.
|
Academic Article
|
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes.
|
Academic Article
|
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies.
|
Academic Article
|
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency.
|
Academic Article
|
EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.
|
Academic Article
|
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
|
Academic Article
|
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
|
Academic Article
|
Rab25 augments cancer cell invasiveness through a ?1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
|
Academic Article
|
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.
|
Academic Article
|
Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2a-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase Expression.
|
Academic Article
|
Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro.
|
Academic Article
|
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
|
Academic Article
|
BRD4 facilitates replication stress-induced DNA damage response.
|
Academic Article
|
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
|
Academic Article
|
RNA editing derived epitopes function as cancer antigens to elicit immune responses.
|
Academic Article
|
Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery.
|
Academic Article
|
Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance.
|
Academic Article
|
?-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.
|
Academic Article
|
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.
|
Academic Article
|
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors.
|
Academic Article
|
Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer.
|
Academic Article
|
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
|
Academic Article
|
Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer.
|
Academic Article
|
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models.
|
Academic Article
|
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.
|
Academic Article
|
Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis.
|
Academic Article
|
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
|
Academic Article
|
Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness.
|
Academic Article
|
AKT isoform-specific expression and activation across cancer lineages.
|
Academic Article
|
Prospective Clinical Sequencing of Adult Glioma.
|
Academic Article
|
GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and ?-catenin activity.
|
Academic Article
|
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer.
|
Academic Article
|
Next-generation characterization of the Cancer Cell Line Encyclopedia.
|
Academic Article
|
The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer.
|
Academic Article
|
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy.
|
Academic Article
|
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling.
|
Academic Article
|
COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.
|
Academic Article
|
Comprehensive characterization of circular RNAs in ~?1000 human cancer cell lines.
|
Academic Article
|
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
|
Academic Article
|
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.
|
Academic Article
|
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.
|
Academic Article
|
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.
|
Academic Article
|
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy.
|
Academic Article
|
Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression.
|
Academic Article
|
Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein Arrays.
|
Academic Article
|
Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.
|
Academic Article
|
p85? regulates autophagic degradation of AXL to activate oncogenic signaling.
|
Academic Article
|
Systems approach to rational combination therapy: PARP inhibitors.
|
Academic Article
|
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling.
|
Academic Article
|
Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways.
|
Academic Article
|
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models.
|
Academic Article
|
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
|
Academic Article
|
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma.
|
Academic Article
|
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.
|
Academic Article
|
Transient commensal clonal interactions can drive tumor metastasis.
|
Academic Article
|
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.
|
Academic Article
|
Hormonal modulation of ESR1 mutant metastasis.
|
Academic Article
|
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.
|
Academic Article
|
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response.
|
Academic Article
|
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
|
Academic Article
|
CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models.
|
Academic Article
|
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas.
|
Academic Article
|
BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators.
|
Academic Article
|
Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.
|
Academic Article
|
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway.
|
Academic Article
|
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas.
|
Academic Article
|
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.
|
Academic Article
|
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs.
|
Academic Article
|
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors.
|
Academic Article
|
BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer.
|
Academic Article
|
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity.
|